Implication of cardiac remodeling in heart failure: mechanisms and therapeutic strategies
- PMID: 12857042
- DOI: 10.2169/internalmedicine.42.465
Implication of cardiac remodeling in heart failure: mechanisms and therapeutic strategies
Abstract
The concept and clinical implication of left ventricular remodeling have been gradually extended. Cardiac remodeling plays important roles in the progression of cardiovascular diseases including myocardial infarction, valvular heart diseases, myocarditis, and dilated cardiomyopathy. In addition to cardiac myocytes, fibroblasts, extracellular matrix proteins and coronary vasculature are also involved in the remodeling process. Cardiac remodeling is associated with alterations of many mediators such as neurohumoral factors, cytokines, enzymes, ion channels, oxidative stress and mechanical stress. Although remodeling is initially an adaptive response to maintain normal cardiac function, it gradually becomes maladaptive and leads to progressive decompensation. Recent research has attempted to elucidate underlying molecular mechanisms of cardiac remodeling and to develop novel therapeutic strategies for heart failure. The modulation of remodeling process is effective for preventing the progression of heart failure.
Similar articles
-
Pharmacological modulation of cardiovascular remodeling: a guide to heart failure therapy.Cardiovasc Drugs Ther. 2003 Jul;17(4):349-60. doi: 10.1023/a:1027351808326. Cardiovasc Drugs Ther. 2003. PMID: 14618097 Review.
-
Reverse Cardiac Remodeling: A Marker of Better Prognosis in Heart Failure.Arq Bras Cardiol. 2015 Jun;104(6):502-6. doi: 10.5935/abc.20150025. Epub 2015 Mar 27. Arq Bras Cardiol. 2015. PMID: 26131706 Free PMC article. Review.
-
Soluble guanylyl cyclase activation improves progressive cardiac remodeling and failure after myocardial infarction. Cardioprotection over ACE inhibition.Basic Res Cardiol. 2014 Jul;109(4):421. doi: 10.1007/s00395-014-0421-1. Epub 2014 Jun 8. Basic Res Cardiol. 2014. PMID: 24907870
-
Assessment of ventricular remodeling in heart failure clinical trials.Curr Heart Fail Rep. 2012 Dec;9(4):328-36. doi: 10.1007/s11897-012-0116-6. Curr Heart Fail Rep. 2012. PMID: 22983907 Review.
-
Effect of the addition of a beta-blocker on left ventricular remodeling and prognosis in patients with dilated cardiomyopathy treated with angiotensin-converting enzyme inhibitor.J Cardiovasc Pharmacol. 2003 Jan;41 Suppl 1:S5-10. J Cardiovasc Pharmacol. 2003. PMID: 12688389
Cited by
-
Pro/Anti-inflammatory cytokine imbalance in postischemic left ventricular remodeling.Mediators Inflamm. 2010;2010:974694. doi: 10.1155/2010/974694. Epub 2010 May 9. Mediators Inflamm. 2010. PMID: 20467464 Free PMC article.
-
PKCβII inhibition attenuates myocardial infarction induced heart failure and is associated with a reduction of fibrosis and pro-inflammatory responses.J Cell Mol Med. 2011 Aug;15(8):1769-77. doi: 10.1111/j.1582-4934.2010.01174.x. J Cell Mol Med. 2011. PMID: 20874717 Free PMC article.
-
Effects of G-CSF on left ventricular remodeling and heart failure after acute myocardial infarction.J Mol Med (Berl). 2006 Mar;84(3):185-93. doi: 10.1007/s00109-005-0035-z. Epub 2006 Jan 17. J Mol Med (Berl). 2006. PMID: 16418824 Review.
-
Effect of renal sympathetic denervation on ventricular and neural remodeling.Herz. 2019 Dec;44(8):717-725. doi: 10.1007/s00059-018-4698-y. Epub 2018 Apr 12. Herz. 2019. PMID: 29651618 Free PMC article.
-
Clofibrate Treatment Decreases Inflammation and Reverses Myocardial Infarction-Induced Remodelation in a Rodent Experimental Model.Molecules. 2019 Jan 12;24(2):270. doi: 10.3390/molecules24020270. Molecules. 2019. PMID: 30642049 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical